Patent application number | Description | Published |
20090177920 | Automated Configuration of Medical Practice Management Systems - A user (e.g., medical office manager, medical office insurance administrator, doctor) utilizes a medical practice configuration interface (e.g., web page) to input information about the user's medical practice (e.g., address, insurance plans, doctors, hospitals that the doctors utilize). Based on this information and/or rules associated with the insurance plans accepted at the user's medical practice, additional information is requested from the user about the user's medical practice (e.g., information needed for an insurance plan, information needed for a hospital). The user inputs the requested additional information utilizing the medical practice configuration interface. Configuration information for the user's medical practice is generated based on the information and/or the additional information inputted by the user. A user interface (e.g., web pages interfacing with the medical practice management server) and/or rules for the medical practice can be generated based on the configuration information. | 07-09-2009 |
20090281831 | Automated Configuration of Medical Practice Management Systems - A user (e.g., medical office manager, medical office insurance administrator, doctor) utilizes a medical practice configuration interface (e.g., web page) to input information about the user's medical practice (e.g., address, insurance plans, doctors, hospitals that the doctors utilize). Based on this information and/or rules associated with the insurance plans accepted at the user's medical practice, additional information is requested from the user about the user's medical practice (e.g., information needed for an insurance plan, information needed for a hospital). The user inputs the requested additional information utilizing the medical practice configuration interface. Configuration information for the user's medical practice is generated based on the information and/or the additional information inputted by the user. A user interface (e.g., web pages interfacing with the medical practice management server) and/or rules for the medical practice can be generated based on the configuration information. | 11-12-2009 |
20120059663 | METHODS AND APPARATUS FOR PATIENT VISIT WORKFLOW - Methods and apparatus for facilitating the collection of information during a patient visit to a healthcare provider. Each of plurality of tasks to be performed during a patient visit are associated with a stages of the patient visit. One or more users are guided through the stages of the patient visit to complete the associated tasks associated with each stage. A user interface associated with an electronic health records system displays pages for each stage that enable the users to enter information during the patient visit. The amount of time that users spend entering information in the electronic health records system during each stage is tracked and is used to generate one or more reports that enable a medical practice to improve the patient visit workflow. | 03-08-2012 |
20120173258 | METHODS AND APPARATUS FOR QUALITY MANAGEMENT OF HEALTHCARE DATA - Methods and apparatus for providing clinical decision support to a healthcare provider. Eligibility criteria and quality measure information for a plurality of performance-based programs is stored and shared quality measures across performance-based programs are identified. Provider and patient characteristics are compared to the stored eligibility criteria and quality measure information to determine which quality measures apply to which providers and patients of the providers. A healthcare provider is provided with a notification at the point of care indicating a recommended action that, when performed by the healthcare provider will satisfy a quality measure in compliance with one or more performance-based programs. Customized reports may be generated and transmitted to program sponsors of performance-based programs, based on formatting rules specified by the program sponsors. | 07-05-2012 |
Patent application number | Description | Published |
20080216830 | RESPIRATORY GAS HUMIDIFIER ADAPTER WITH PRESSURE RELIEF VALVE AND AUDIBLE SIGNAL GENERATOR - A pressurized respiratory gas humidifier adapter with a pressure relief valve having an audible signal generating device incorporated into a low-flow respiratory gas supply system at a position in the system wherein the pressure relief valve and an audible signal generating device are protected from inadvertent damage during use of the humidification system, especially during connection of the adapter into the respiratory gas supply system and when the adapter is connected to a humidifier container prior to coupling into the gas supply system. The pressure relief valve and audible signal generator are incorporated into a humidifier adapter for creating a hermetic seal with a standard medical humidifier container, and the pressure relief valve relieves and regulates the pressure in the humidified gas supply system when an obstruction in the gas flow path to the patient occurs, while generating an audible sound emitted at a predetermined pressure threshold level throughout a desired respiratory gas flow-rate range. | 09-11-2008 |
20090056711 | Nose Cannula Heated/Humidified Gas Delivery System - A low flow heated/humidified respiratory gas delivery system, especially useful for low flow rates as preferred in the treatment of neonate and other such patients, wherein the respiratory gas is heated and humidified as desired for delivery to the patient and the temperature is monitored at the point of delivery to the patient. | 03-05-2009 |
20090056717 | NOSE CANNULA HEATED/HUMIDIFIED GAS DELIVERY SYSTEM - A low flow heated/humidified respiratory gas delivery system, especially useful for low flow rates as preferred in the treatment of neonate and other such patients, wherein the respiratory gas is heated and humidified as desired for delivery to the patient and the temperature is monitored at the point of delivery to the patient. | 03-05-2009 |
20120216808 | Nose Cannula Heated/Humidified Gas Delivery System - A low flow heated/humidified respiratory gas delivery system, especially useful for low flow rates as preferred in the treatment of neonate and other such patients, wherein the respiratory gas is heated and humidified as desired for delivery to the patient and the temperature is monitored at the point of delivery to the patient. | 08-30-2012 |
20120247468 | Nose Cannula Heated/Humidified Gas Delivery System - A low flow heated/humidified respiratory gas delivery system, especially useful for low flow rates as preferred in the treatment of neonate and other such patients, wherein the respiratory gas is heated and humidified as desired for delivery to the patient and the temperature is monitored at the point of delivery to the patient. | 10-04-2012 |
Patent application number | Description | Published |
20100247656 | Method for in situ Generation of Molecular Iodine on Mucus Membranes Using Nanoparticles - Nano-particles created using a biodegradable chemical backbone structure suitably designed to permit creation of at least two populations of nano-particles that contain chemical compositions. A first population of particles can contain iodide (I | 09-30-2010 |
20100310621 | Controlled Iodine Release Particle Micro-Biocide - A controlled release molecular iodine biocide for use in human cavities especially the vaginal, penile canal, nasal passages and rectum. Particles can be functionalized with epithelial cell binding molecules and lymphocyte-binding molecules attached to their surfaces. Half of all the particles can contain pH buffer salts that control pH to between around pH 3.5 to pH 4.5. A second half of the particles can contain Iodide and iodate salts. When pH particles and iodate/iodide particles are bound next to each other, molecular iodine is released in a controlled fashion. Molecular iodine is effective biocide. In an alternate embodiment, there can be two distinct populations of particles, one with epithelial cell binding molecules and one with lymphocyte-binding molecules. Again, half of all the particles can contain a pH buffer and half iodide and iodate salts. | 12-09-2010 |
20110195033 | Automated Method and System for Introducing Molecular Iodine into Drinking Water - A system and method for delivering molecular iodine or any other substance into a pet's drinking water on a daily basis without exceeding the safe amount allowed for the pet. The present invention delivers a particular amount of molecular iodine into the pet water supply to achieve maximum benefit of I | 08-11-2011 |
20120179085 | Device and Process for Creation of Active Antimicrobial Iodine from Inactive Iodine - A device and process that creates active molecular iodine on a swab. The device has two chambers sealed from one-another. One of the chambers contains a swab. Each chamber contains a different reagent such that when the device is broken or crushed to activate it, the contents of both chambers mix on the swab. The reagents are such that, when mixed, they produce molecular iodine on the swab which acts as a topical antiseptic. The reagents can be an iodide in one chamber and an iodate in the second chamber with a buffer. Alternatively one of the chambers can contain dry molecular iodine in contact with the swab. Finally, one of the chambers can contain molecular iodine in a solution of ethanol, while the other can contain a aqueous solution of a buffer to maintain a proper pH. | 07-12-2012 |
20130298839 | DEVICE AND METHOD FOR ADMINISTERING ORAL DISINFECTING SOLUTIONS AND OTHER MEDICAMENTS - Embodiments of the present invention feature devices and methods for administering medicaments to subjects and, in particular, molecular iodine to animals in drinking water for the treatment of oral bad breath and disease. An exemplary device comprises a source of medicament in a fluid, measuring means, an administration switch and a water reservoir means. The measuring means is in fluid communication with said source of medicament for measuring an aliquot of medicament corresponding to a dose for the treatment of a disease. The measuring means is also in communication with a water reservoir means and releases the aliquot into the water reservoir means upon signal activation. The administration switch means is in signal communication with the measuring means and upon activation by a subject produces an activation signal received by the measuring means. The water reservoir means is for receiving the aliquot and forming an aqueous solution of medicament. | 11-14-2013 |
20140158057 | Automated Method and System for Introducing Molecular Iodine into Drinking Water - A system for delivering molecular iodine or other substance into a pet's drinking water on a daily basis without exceeding the safe amount allowed for the pet. The system delivers a particular amount of molecular iodine into the pet water supply to achieve maximum benefit of I | 06-12-2014 |
Patent application number | Description | Published |
20100055090 | 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS - The present invention relates to novel Anilinopiperazine Derivatives of formula (I), compositions comprising the Anilinopiperazine Derivatives, and methods for using the Anilinopiperazine Derivatives for treating or preventing a proliferative disorder, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease, a fungal infection, or a disorder related to the activity of a protein kinase. | 03-04-2010 |
20100130465 | 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS - The present invention relates to novel Anilinopiperazine Derivatives of formula (I), compositions comprising the Anilinopiperazine Derivatives, and methods for using the Anilinopiperazine Derivatives for treating or preventing a proliferative disorder, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease, a fungal infection, or a disorder related to the activity of a protein kinase. | 05-27-2010 |
20110044940 | Thiazole Carboxamide Derivatives and Their Use to Treat Cancer - The present invention relates to novel Heterocyclic Ether or Thioether Derivatives, compositions comprising the Heterocyclic Ether or Thioether Derivatives, and methods for using the Heterocyclic Ether or Thioether Derivatives for treating or preventing a proliferative disorder, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral infection, a fungal infection, or a disorder related to the activity of a protein kinase. | 02-24-2011 |
20120114739 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS - The present invention provides methods for inhibiting mTOR using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with mTOR using such compounds. | 05-10-2012 |
20120328691 | ANILINOPIPERAZINE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to novel Anilinopiperazine Derivatives of Formula (I), compositions comprising the Anilinopiperazine Derivatives, and methods for using the Anilinopiperazine Derivatives for treating or preventing a proliferative disorder, cancer, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease, a fungal infection, or a disorder related to the activity of a protein kinase. | 12-27-2012 |